Global Biologics CDMO Market Report 2024

Biologics CDMO Global Market Report 2024 – By Cell Type (Mammalian, Non-Mammalian), By Product Type (Biologics, Biosimilars) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : April 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Biologics CDMO Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Biologics CDMO Market Definition And Segments

A biologics contract development and manufacturing organization (CDMO) is a service provider that supports pharmaceutical companies in the development and production of biologic drugs, which include vaccines, blood and blood components, allergens, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins.

The main cell types in biologics CDMO are mammalian and non-mammalian. Mammalian refers to cell lines derived from mammals, commonly used in the production of biologics and cell-based therapies due to their ability to produce complex proteins and maintain post-translational modifications. The various products types include biologics and biosimilars.

The biologics CDMO market covered in this report is segmented –

1) By Cell Type: Mammalian, Non-Mammalian

2) By Product Type: Biologics, Biosimilars

The biologics CDMO market size has grown rapidly in recent years. It will grow from $18.44 billion in 2023 to $21.30 billion in 2024 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to rise in biologics development, cost efficiency and flexibility, focus on core competencies, regulatory compliance and quality assurance, globalization of pharmaceutical supply chains.

The biologics CDMO market size is expected to see rapid growth in the next few years. It will grow to $36.54 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing demand for biologic therapies, emergence of biosimilars and biobetters, investments in biomanufacturing infrastructure, shift towards outsourcing complex processes, focus on supply chain resilience and risk mitigation, regulatory harmonization, and expedited approvals. Major trends in the forecast period include expansion of capabilities to offer end-to-end solutions, adoption of single-use technologies, integration of continuous manufacturing processes, emergence of specialized CDMOs.

Rise In Demand For Cell And Genetic Therapy Fuels Biologics CDMO Market Growth

The surge in demand for cell and genetic therapy is expected to propel the growth of the biologic CDMO market going forward. Cell and gene therapy are innovative medical approaches that utilize living cells or genetic material to address underlying disease causes at the cellular or genetic level, providing potential treatments for conditions that are difficult to manage or incurable with traditional pharmaceuticals. The demand for cell and gene therapy is rising due to their potential to offer innovative treatments for diseases by addressing underlying genetic or cellular causes. Biologic CDMOs provide expertise in handling living cells, viral vectors, and genetic material, facilitating safe and efficient production of cell and gene therapies while assisting biopharmaceutical companies in navigating regulatory requirements and technical challenges, thereby facilitating translation from research to clinical application. For instance, in January 2023, according to The American Society of Gene & Cell Therapy (ASGCT), a US-based primary professional membership organization, the gene, cell, and RNA therapy pipeline saw 7% growth in 2022, reaching a total of 3,726 therapies in development. Of these, 55% are gene therapies, while 22% are non-genetically modified cell therapies, and 23% are RNA therapies. Therefore, the surge in demand for cell and genetic therapy is driving the growth of the biologic CDMO market.

Major companies operating in the biologics CDMO market are AbbVie Inc., Thermo Fisher Scientific Inc., Novartis AG, Evonik Industries AG, Sandoz International GmbH, ICON PLC, Grifols SA, Lonza Group Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., JSR Corp., Parexel International Corporation, WuXi Biologics (Cayman) Inc., Samsung Biologics Co. Ltd., Emergent BioSolutions Inc., Rentschler Biopharma SE, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Binex Co. Ltd., Bora Pharmaceuticals Co. Ltd, 3P Biopharmaceuticals s.l.u, JRS Pharma LP, J Rettenmaier and SOHNE GmbH and Co KG, Kemwell Biopharma Pvt. Ltd., Cytovance Biologics, AGC Biologics, Shenzhen Hepalink Pharmaceutical Co. Ltd.

Advancements In Biologics CDMO

Major companies operating in the biologics CDMO market are developing technologically advanced solutions, such as new cell lines, to enhance biopharmaceutical development and manufacturing efficiency and capabilities. The technology produces therapeutic antibodies with enhanced potency, addressing immunotherapy research and development challenges. For instance, in November 2023, Lonza Group, a Switzerland-based manufacturing company that specializes in the pharmaceutical and biotechnology sectors, launched GS Effex cell lines, designed to produce antibodies that are 100% free of fucose, a sugar molecule and demonstrate increased potency without compromising on other performance attributes. It helps overcome immunotherapy research and development challenges related to the need for antibody therapeutics to increase potency. It is a stable, scalable, and productive cell line that provides a solution for therapeutic development from discovery-stage research through commercial manufacturing.

Bora Pharmaceuticals Expands Global Footprint With Acquisition Of Eden Biologics Inc.

In May 2022, Bora Pharmaceuticals Co. Ltd., a Taiwan-based organization that specializes in manufacturing and selling pharmaceutical products, acquired the CDMO assets of Eden Biologics Inc. for $100 million. The aim of the acquisition is to expand its presence in the global CDMO market, particularly focusing on biologics, macromolecules, and cell and gene therapy markets. Eden Biologics Inc. is a Taiwan-based biotechnology company specializing in the contract development and manufacturing of innovative biologics for therapeutic applications.

North America was the largest region in the biologics CDMO market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biologics CDMO market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biologics CDMO market consist of revenues earned by entities by providing services such as process development, analytical development, cell line development, supply chain management, and fill-finish services. The biologics CDMO market also includes sales of monoclonal antibodies, recombinant proteins, antisense and molecular therapy, and vaccines. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The biologics CDMO research report is one of a series of new reports from The Business Research Company that provides biologics CDMO market statistics, including the biologics CDMO industry's global market size, regional shares, competitors with an biologics CDMO market share, detailed biologics CDMO market segments, market trends and opportunities, and any further data you may need to thrive in the biologics CDMO industry. This biologics CDMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Biologics CDMO Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $21.30 billion
Revenue Forecast In 2033 $36.54 billion
Growth Rate CAGR of 14.4% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Cell Type: Mammalian, Non-Mammalian
2) By Product Type: Biologics, Biosimilars
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled AbbVie Inc.; Thermo Fisher Scientific Inc.; Novartis AG; Evonik Industries AG; Sandoz International GmbH; ICON PLC; Grifols SA; Lonza Group Ltd.; Boehringer Ingelheim International GmbH; Catalent Inc.; JSR Corp.; Parexel International Corporation; WuXi Biologics (Cayman) Inc.; Samsung Biologics Co. Ltd.; Emergent BioSolutions Inc.; Rentschler Biopharma SE; FUJIFILM Diosynth Biotechnologies U.S.A. Inc.; Binex Co. Ltd.; Bora Pharmaceuticals Co. Ltd; 3P Biopharmaceuticals s.l.u; JRS Pharma LP; J Rettenmaier and SOHNE GmbH and Co KG; Kemwell Biopharma Pvt. Ltd.; Cytovance Biologics; AGC Biologics; Shenzhen Hepalink Pharmaceutical Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Biologics CDMO Market Characteristics

    3. Biologics CDMO Market Trends And Strategies

    4. Biologics CDMO Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Biologics CDMO Market Size and Growth

    5.1. Global Biologics CDMO Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Biologics CDMO Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Biologics CDMO Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Biologics CDMO Market Segmentation

    6.1. Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Mammalian

    Non-Mammalian

    6.2. Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Biologics

    Biosimilars

    7. Biologics CDMO Market Regional And Country Analysis

    7.1. Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Biologics CDMO Market

    8.1. Asia-Pacific Biologics CDMO Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Biologics CDMO Market

    9.1. China Biologics CDMO Market Overview

    9.2. China Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Biologics CDMO Market

    10.1. India Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Biologics CDMO Market

    11.1. Japan Biologics CDMO Market Overview

    11.2. Japan Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Biologics CDMO Market

    12.1. Australia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Biologics CDMO Market

    13.1. Indonesia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Biologics CDMO Market

    14.1. South Korea Biologics CDMO Market Overview

    14.2. South Korea Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Biologics CDMO Market

    15.1. Western Europe Biologics CDMO Market Overview

    15.2. Western Europe Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Biologics CDMO Market

    16.1. UK Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Biologics CDMO Market

    17.1. Germany Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Biologics CDMO Market

    18.1. France Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Biologics CDMO Market

    19.1. Italy Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Biologics CDMO Market

    20.1. Spain Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Biologics CDMO Market

    21.1. Eastern Europe Biologics CDMO Market Overview

    21.2. Eastern Europe Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Biologics CDMO Market

    22.1. Russia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Biologics CDMO Market

    23.1. North America Biologics CDMO Market Overview

    23.2. North America Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Biologics CDMO Market

    24.1. USA Biologics CDMO Market Overview

    24.2. USA Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Biologics CDMO Market

    25.1. Canada Biologics CDMO Market Overview

    25.2. Canada Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Biologics CDMO Market

    26.1. South America Biologics CDMO Market Overview

    26.2. South America Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Biologics CDMO Market

    27.1. Brazil Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Biologics CDMO Market

    28.1. Middle East Biologics CDMO Market Overview

    28.2. Middle East Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Biologics CDMO Market

    29.1. Africa Biologics CDMO Market Overview

    29.2. Africa Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Biologics CDMO Market Competitive Landscape And Company Profiles

    30.1. Biologics CDMO Market Competitive Landscape

    30.2. Biologics CDMO Market Company Profiles

    30.2.1. AbbVie Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Thermo Fisher Scientific Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Novartis AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Evonik Industries AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Sandoz International GmbH

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Biologics CDMO Market Other Major And Innovative Companies

    31.1. ICON PLC

    31.2. Grifols SA

    31.3. Lonza Group Ltd.

    31.4. Boehringer Ingelheim International GmbH

    31.5. Catalent Inc.

    31.6. JSR Corp.

    31.7. Parexel International Corporation

    31.8. WuXi Biologics (Cayman) Inc.

    31.9. Samsung Biologics Co. Ltd.

    31.10. Emergent BioSolutions Inc.

    31.11. Rentschler Biopharma SE

    31.12. FUJIFILM Diosynth Biotechnologies U.S.A. Inc.

    31.13. Binex Co. Ltd.

    31.14. Bora Pharmaceuticals Co. Ltd

    31.15. 3P Biopharmaceuticals s.l.u

    32. Global Biologics CDMO Market Competitive Benchmarking

    33. Global Biologics CDMO Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Biologics CDMO Market

    35. Biologics CDMO Market Future Outlook and Potential Analysis

    35.1 Biologics CDMO Market In 2028 - Countries Offering Most New Opportunities

    35.2 Biologics CDMO Market In 2028 - Segments Offering Most New Opportunities

    35.3 Biologics CDMO Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Asia-Pacific, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: China, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: China, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: India, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: India, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: Japan, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: Japan, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: Australia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: Australia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Indonesia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Indonesia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: South Korea, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: South Korea, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Western Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Western Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: UK, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: UK, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Germany, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Germany, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: France, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: France, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Italy, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Italy, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Spain, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Spain, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Eastern Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: Eastern Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Russia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Russia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: North America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: North America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: USA, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: USA, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Canada, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Canada, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: South America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: South America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Brazil, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Brazil, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Middle East, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Middle East, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Africa, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Africa, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: AbbVie Inc. Financial Performance
  • Table 52: Thermo Fisher Scientific Inc. Financial Performance
  • Table 53: Novartis AG Financial Performance
  • Table 54: Evonik Industries AG Financial Performance
  • Table 55: Sandoz International GmbH Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Asia-Pacific, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: China, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: China, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: India, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: India, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: Japan, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: Japan, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: Australia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: Australia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Indonesia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Indonesia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: South Korea, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: South Korea, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Western Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Western Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: UK, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: UK, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Germany, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Germany, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: France, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: France, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Italy, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Italy, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Spain, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Spain, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Eastern Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: Eastern Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Russia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Russia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: North America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: North America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: USA, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: USA, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Canada, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Canada, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: South America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: South America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Brazil, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Brazil, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Middle East, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Middle East, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Africa, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Africa, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: AbbVie Inc. Financial Performance
  • Figure 52: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 53: Novartis AG Financial Performance
  • Figure 54: Evonik Industries AG Financial Performance
  • Figure 55: Sandoz International GmbH Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Biodegradable Plastics Global Market Report 2024 – By Type (Polylactic Acid (PLA), Polybutylene Adipate Terephthalate (PBAT), Polybutylene Succinate (PBS), PHA (Polyhydroxyalkanoates), Starch Blends, Other Types), By End User (Packaging, Agriculture, Consumer Goods, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Soap And Other Detergents Global Market Report 2024 – By Product Type (Laundry Detergent, Soap, Dishwashing Detergent, Toothpaste, Other Product Types), By Application (Homecare Detergents, Industrial Soap and Detergent, Homecare Soaps, Other Applications), By End User (Body, Clothing, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Detergent Chemicals Global Market Report 2024 – By Product( Surfactants, Builders And Fillers, Enzymes, Fragrances, Bleaching Agents), By Form( Solid Detergents, Liquid Detergents), By Application( Laundry Cleaning Products, Household And Commercial Cleaning Products, Personal Cleaning Products, Dishwashing Products, Fuel Additives, Biological Reagents) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Biometric Payment Global Market Report 2024 – By Type (Contact-Based, Contactless, Hybrid), By Component (Hardware, Software, Services), By Technology (Single Factor Authentication, Fingerprint Recognition, Iris Recognition, Palm Recognition, Face Recognition, Signature Recognition, Voice Recognition, Biometric Smart Card, Multimodal), By Mode Of Payment (Smartphone And Tablet, Biometric And Smart Cards, Other Modes), By Application (Banking, Financial Services And Insurance (BFSI), Retail And Ecommerce, Travel And Hospitality, Transportation, Healthcare, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Wood Bio-Products Global Market Report 2024 – By Product Type (Biofuels, Bioplastics, Biochemicals, Biocomposites, Pulp And Papers), By Distribution Channel (Offline, Online), By Application (Energy, Packaging, Construction, Automotive, Chemicals), By End Use Industry (Residential, Commercial, Industrial, Infrastructure, Other End Use Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Biometrics-As-A-Service Global Market Report 2024 – By Scanner Type (Fingerprint Recognition, Iris Recognition, Palm Recognition, Facial Recognition, Voice Recognition, Other Scanner Types), By Modality (Unimodal, Multimodal), By Deployment Model (Public Cloud, Private Cloud, Hybrid Cloud), By Application (Site Access Control, Time Recording, Mobile Application, Web And Workplace), By End-User (Government, Retail, IT (Information Technology) And Telecom, Banking, Financial Services And Insurance (BFSI), Healthcare, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Biodegradable Films Global Market Report 2024 – By Type (Polylactic Acid (PLA), Starch Blends, Biodegradable Polyesters, Polyhydroxyalkanoates (PHA), Other Types), By Application (Bags, Mulch Films, Wrapping Films, Liners, Other Applications), By End-Use (Food And Beverage, Healthcare, Personal Care And Cosmetics, Agriculture, Metal, Glass, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Biodegradable Paper and Plastic Packaging Global Market Report 2024 – By Type (Starch Based Plastic, Cellulose Based Plastic, Polylactic Acid (PLA), Polyhydroxyalkanoates (PHA), Other Types), By Material (Paper, Plastic), By Application (Beverage Packaging, Personal And Home Care Packaging, Electronic Appliance Packaging, Food Packaging, Pharmaceutical Packaging, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the biologics CDMO market?

A biologics contract development and manufacturing organization (CDMO) is a service provider that supports pharmaceutical companies in the development and production of biologic drugs, which include vaccines, blood and blood components, allergens, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. For further insights on the biologics CDMO market, request a sample here

How will the biologics CDMO market drivers and restraints affect the biologics CDMO market dynamics? What forces will shape the biologics CDMO industry going forward?

The biologics CDMO market major growth driver - Rise In Demand For Cell And Genetic Therapy Fuels Biologics CDMO Market Growth. For further insights on the biologics CDMO market, request a sample here

What is the forecast market size or the forecast market value of the biologics CDMO market?

The biologics CDMO market size has grown rapidly in recent years. It will grow from $18.44 billion in 2023 to $21.30 billion in 2024 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to rise in biologics development, cost efficiency and flexibility, focus on core competencies, regulatory compliance and quality assurance, globalization of pharmaceutical supply chains. The biologics CDMO market size is expected to see rapid growth in the next few years. It will grow to $36.54 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing demand for biologic therapies, emergence of biosimilars and biobetters, investments in biomanufacturing infrastructure, shift towards outsourcing complex processes, focus on supply chain resilience and risk mitigation, regulatory harmonization, and expedited approvals. Major trends in the forecast period include expansion of capabilities to offer end-to-end solutions, adoption of single-use technologies, integration of continuous manufacturing processes, emergence of specialized CDMOs. For further insights on the biologics CDMO market, request a sample here

How is the biologics CDMO market segmented?

The biologics CDMO market is segmented
1) By Cell Type: Mammalian, Non-Mammalian
2) By Product Type: Biologics, BiosimilarsFor further insights on the biologics CDMO market, request a sample here

Which region has the largest share of the biologics CDMO market? What are the other regions covered in the report?

North America was the largest region in the biologics CDMO market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the biologics CDMO market, request a sample here.

Who are the major players in the biologics CDMO market?

Major companies operating in the biologics CDMO market are AbbVie Inc., Thermo Fisher Scientific Inc., Novartis AG, Evonik Industries AG, Sandoz International GmbH, ICON PLC, Grifols SA, Lonza Group Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., JSR Corp., Parexel International Corporation, WuXi Biologics (Cayman) Inc., Samsung Biologics Co. Ltd., Emergent BioSolutions Inc., Rentschler Biopharma SE, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Binex Co. Ltd., Bora Pharmaceuticals Co. Ltd, 3P Biopharmaceuticals s.l.u, JRS Pharma LP, J Rettenmaier and SOHNE GmbH and Co KG, Kemwell Biopharma Pvt. Ltd., Cytovance Biologics, AGC Biologics, Shenzhen Hepalink Pharmaceutical Co. Ltd. For further insights on the biologics CDMO market, request a sample here.

What are the key trends in the biologics CDMO market?

Major trend in the biologics CDMO market - Advancements In Biologics CDMO. For further insights on the biologics CDMO market, request a sample here.

What are the major opportunities in the biologics CDMO market? What are the strategies for the biologics CDMO market?

For detailed insights on the major opportunities and strategies in the biologics CDMO market, request a sample here.

How does the biologics CDMO market relate to the overall economy and other similar markets?

For detailed insights on biologics CDMO market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the biologics CDMO industry?

For detailed insights on the mergers and acquisitions in the biologics CDMO industry, request a sample here.

What are the key dynamics influencing the biologics CDMO market growth? SWOT analysis of the biologics CDMO market.

For detailed insights on the key dynamics influencing the biologics CDMO market growth and SWOT analysis of the biologics CDMO industry, request a sample here.